The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

Category: Pharma & Human Health

Kanvas Biosciences Secures $48M Series A to advance lead immuno-oncology drug
Finance

Kanvas Biosciences Secures $48M Series A to advance lead immuno-oncology drug

MAY 8, 2026
Engineered commensals for metabolic modulation of the gut-liver-brain axis
Gut-Brain Axis

Engineered commensals for metabolic modulation of the gut-liver-brain axis

MAY 4, 2026
LACTIN-V: A Promising Live Biotherapeutic for Recurrent Bacterial Vaginosis
Editor's Choice

LACTIN-V: A Promising Live Biotherapeutic for Recurrent Bacterial Vaginosis

MAY 1, 2026
EnteroBiotix Secures £19m to Initiate Phase 2b Clinical Trial for IBS
Clinical & Manufacturing

EnteroBiotix Secures £19m to Initiate Phase 2b Clinical Trial for IBS

APR 30, 2026
mbiomics Announces Third Closing of Series A, Reaching €30 Million to Advance Microbiome Therapeutics
Finance

mbiomics Announces Third Closing of Series A, Reaching €30 Million to Advance Microbiome Therapeutics

APR 28, 2026
Freya Biosciences announces positive Phase 1 data for IVF-related embryo implantation failure
Clinical & Manufacturing

Freya Biosciences announces positive Phase 1 data for IVF-related embryo implantation failure

APR 16, 2026
Lactic Acid’s Untapped Potential to Optimise the Vaginal Microbiota and Mucosal Environment
Editor's Choice

Lactic Acid’s Untapped Potential to Optimise the Vaginal Microbiota and Mucosal Environment

APR 8, 2026
Women’s Health Innovation Is Not Failing – The System Around It Is
Finance

Women’s Health Innovation Is Not Failing – The System Around It Is

MAR 31, 2026
Multi-strain probiotic therapy shows promise in preventing bacterial vaginosis recurrence
Biotics and Supplements

Multi-strain probiotic therapy shows promise in preventing bacterial vaginosis recurrence

MAR 24, 2026
Qiagen unveils new high-throughput benchtop automation system
Pharma & Human Health

Qiagen unveils new high-throughput benchtop automation system

MAR 20, 2026
Opella announces strategic partnership with Verb Biotics for development of next-generation probiotic strain
Biotics and Supplements

Opella announces strategic partnership with Verb Biotics for development of next-generation probiotic strain

MAR 13, 2026